ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 193 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $202,955 | -41.5% | 5,693 | -34.2% | 0.00% | 0.0% |
Q1 2023 | $346,785 | +3052.6% | 8,648 | +6552.3% | 0.00% | – |
Q4 2021 | $11,000 | +266.7% | 130 | +333.3% | 0.00% | – |
Q3 2021 | $3,000 | -96.5% | 30 | -96.7% | 0.00% | – |
Q2 2021 | $86,000 | +681.8% | 901 | +828.9% | 0.00% | – |
Q1 2021 | $11,000 | +37.5% | 97 | -4.0% | 0.00% | – |
Q2 2020 | $8,000 | -84.6% | 101 | -91.4% | 0.00% | – |
Q1 2020 | $52,000 | +300.0% | 1,178 | +288.8% | 0.00% | – |
Q4 2019 | $13,000 | +550.0% | 303 | +482.7% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 52 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | – | 52 | +642.9% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 7 | -99.2% | 0.00% | -100.0% |
Q2 2018 | $64,000 | -9.9% | 829 | -17.8% | 0.00% | 0.0% |
Q4 2016 | $71,000 | +129.0% | 1,009 | +131.4% | 0.00% | – |
Q3 2016 | $31,000 | -89.7% | 436 | -92.9% | 0.00% | -100.0% |
Q2 2016 | $300,000 | +59.6% | 6,125 | +106.0% | 0.00% | +33.3% |
Q1 2016 | $188,000 | +506.5% | 2,974 | +315.4% | 0.00% | – |
Q4 2014 | $31,000 | -52.3% | 716 | -38.0% | 0.00% | -100.0% |
Q3 2014 | $65,000 | +261.1% | 1,155 | +188.8% | 0.00% | – |
Q2 2014 | $18,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |